Wize Pharma (Israel) Profile

Risk Adjusted Return

From 0 to 100

   

Chance of Distress     

From 0 to 100%

Equity ratings for Wize Pharma are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting February 24, 2019 and ending today April 25, 2019. Click here to learn more.
Wize Pharma Ltd. develops, manufactures, and markets electrooptical systems for night vision in Israel, Switzerland, India, and internationally. more
NameWize Pharma
CEOOr EisenbergView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business Address, Granit StreetPetah Tikva,
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
BenchmarkDOW
Phone972 3 232 4501
CurrencyILS - Israeli Shekel

Wize PharmaCorporate Directors

Ilan Neugarten Independent Director
Lior Sibahi Director
Ronen Solomon Director
See also Your Current Watchlist. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.
Search macroaxis.com